E. Guler Et Al. , "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance," International Journal of Pharmaceutics , vol.635, 2023
Guler, E. Et Al. 2023. Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance. International Journal of Pharmaceutics , vol.635 .
Guler, E., Nur Hazar-Yavuz, A., Tatar, E., Morid Haidari, M., Sinemcan Ozcan, G., Duruksu, G., ... Graça, M. P. F.(2023). Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance. International Journal of Pharmaceutics , vol.635.
Guler, Ece Et Al. "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance," International Journal of Pharmaceutics , vol.635, 2023
Guler, Ece Et Al. "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance." International Journal of Pharmaceutics , vol.635, 2023
Guler, E. Et Al. (2023) . "Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance." International Journal of Pharmaceutics , vol.635.
@article{article, author={Ece Guler Et Al. }, title={Oral empagliflozin-loaded tri-layer core-sheath fibers fabricated using tri-axial electrospinning: Enhanced in vitro and in vivo antidiabetic performance}, journal={International Journal of Pharmaceutics}, year=2023}